Molecular Drivers of Cardiomyocyte Maturation

Establishing cardiomyocytes derived from human induced pluripotent stem cells has great potential as a cell source for therapeutic applications, such as regenerative medicine. Discover the latest research on Molecular Drivers of Cardiomyocyte Maturation here.

January 12, 2021

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Journal of Visualized Experiments : JoVE
Fitzwilliam SeibertzNiels Voigt
January 13, 2021

Human induced pluripotent stem cell derived cardiomyocytes: the new working horse in cardiovascular pharmacology?

Journal of Cardiovascular Pharmacology
Marc D Lemoine, Torsten Christ
December 19, 2020
Review

Molecular Imaging of Atrial Myopathy: Towards Early AF detection and Non-invasive Disease Management

Trends in Cardiovascular Medicine
Martin EzeaniBe'eri Niego
January 16, 2021

Relationships Between Constituents of Energy Drinks and Beating Parameters in Human Induced Pluripotent Cell (iPSC)-Derived Cardiomyocytes

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Yu-Syuan LuoIvan Rusyn
January 7, 2021

4D Printed Cardiac Construct with Aligned Myofibers and Adjustable Curvature for Myocardial Regeneration

ACS Applied Materials & Interfaces
Yue WangLijie Grace Zhang
January 9, 2021

Beige adipocytes contribute to breast cancer progression

Oncology Reports
Mariana GantovJudith Toneatto
January 4, 2021
Open Access

Telomerase therapy attenuates cardiotoxic effects of doxorubicin

Molecular Therapy : the Journal of the American Society of Gene Therapy
Shambhabi ChatterjeeChristian Bär
December 17, 2020
Open Access

Functionalised peptide hydrogel for the delivery of cardiac progenitor cells

Materials Science & Engineering. C, Materials for Biological Applications
K A BurgessA Saiani
January 9, 2021

Donor specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function

American Journal of Physiology. Heart and Circulatory Physiology
Amy TurnerUlrich Broeckel
December 15, 2020
Preprint
Open Access

Oncogene-induced cardiac neoplasia shares similar mechanisms with heart regeneration in zebrafish

BioRxiv : the Preprint Server for Biology
C. PfefferliAnna Jazwinska
January 14, 2021
Open Access

Cellular and molecular landscape of mammalian sinoatrial node revealed by single-cell RNA sequencing

Nature Communications
Dandan LiangYi-Han Chen
December 18, 2020
Open Access

The Regulatory Role of Histone Modification on Gene Expression in the Early Stage of Myocardial Infarction

Frontiers in Cardiovascular Medicine
Jinyu WangYi-Han Chen
January 15, 2021
Open Access

Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids

International Journal of Molecular Sciences
Monia SouidiAlbano C Meli

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

© 2021 Meta ULC. All rights reserved
/feed-previews/molecular-drivers-of-cardiomyocyte/6d18fded-5f3f-4b03-846b-8f9b7554f9ff